首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Small interfering RNA targeting receptor for advanced glycation end products suppresses the generation of proinflammatory cytokines
【2h】

Small interfering RNA targeting receptor for advanced glycation end products suppresses the generation of proinflammatory cytokines

机译:晚期糖基化终产物的小分子干扰RNA靶向受体抑制促炎细胞因子的产生

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of the present study was to investigate the effect of receptor for advanced glycation end products (RAGE)-specific small interfering (si)RNA on the generation of proinflammatory cytokines in primary rat hepatic stellate cells (HSCs) and hepatic fibrotic (HF) rats. The RAGE-specific siRNA expression vector pAKD-GR126 was constructed, and then transfected into primary rat HSCs. Reverse transcription-quantitative polymerase chain reaction and western blot analyses were conducted to determine the mRNA and protein expression levels, respectively, of RAGE, tumor necrosis factor (TNF)-α and interleukin (IL)-6 in the primary HSCs. In addition, a CCl4-induced Sprague Dawley (SD) rat model of hepatic fibrosis was established, and pAKD-GR126 was injected into the SD rats via the tail vein. Serum TNF-α and IL-6 concentrations were determined using radioimmunoassay. The mRNA and protein expression levels of RAGE (mRNA, F=7.791; protein, F=36.513), TNF-α (mRNA, F=474.568; protein, F=123.500) and IL-6 (mRNA, F=203.463; protein, F=320.555) in the pAKD-GR126-transfected primary HSCs were significantly reduced compared with those in the control and pAKD-NC groups (P<0.05). Serum TNF-α and IL-6 levels in the low-, medium- and high-dose pAKD-GR126 treatment groups were reduced compared with those in the fibrotic model group (TNF-α, F=416.397; IL-6, F=1,716.659; P<0.05). In summary, the RAGE-specific siRNA was able to effectively suppress the generation of the proinflammatory cytokines TNF-α and IL-6 in primary rat HSCs and HF rats.
机译:本研究的目的是研究晚期糖基化终产物(RAGE)特异性小干扰(si)RNA受体对原代大鼠肝星状细胞(HSC)和肝纤维化(HF)中促炎细胞因子生成的影响大鼠。构建了RAGE特异性siRNA表达载体pAKD-GR126,然后将其转染到原代大鼠HSC中。进行了逆转录定量聚合酶链反应和蛋白质印迹分析,分别确定了原发性HSC中RAGE,肿瘤坏死因子(TNF)-α和白介素(IL)-6的mRNA和蛋白表达水平。另外,建立了CCl4诱导的肝纤维化Sprague Dawley(SD)大鼠模型,并通过尾静脉将pAKD-GR126注射入SD大鼠。使用放射免疫测定法测定血清TNF-α和IL-6浓度。 RAGE(mRNA,F = 7.791;蛋白质,F = 36.513),TNF-α(mRNA,F = 474.568;蛋白质,F = 123.500)和IL-6(mRNA,F = 203.463;蛋白质)的mRNA和蛋白质表达水平与对照组和pAKD-NC组相比,pAKD-GR126转染的原代HSC中F = 320.555)显着降低(P <0.05)。与纤维化模型组相比,低,中,高剂量pAKD-GR126治疗组的血清TNF-α和IL-6水平降低(TNF-α,F = 416.397; IL-6,F = 1,716.659; P <0.05)。总之,RAGE特异性siRNA能够有效抑制原发性大鼠HSC和HF大鼠中促炎性细胞因子TNF-α和IL-6的产生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号